Beleaguered Bayer CEO Werner Baumann has clinched the support of two major investors, but shareholder concerns surrounding the German conglomerate’s C-suite payouts persist.

Prominent proxy brawlers Institutional Shareholder Services (ISS) and Glass Lewis have endorsed Bayer’s leadership but stopped short of blessing its “excessive” executive compensation plans, Bloomberg News first reported. The investors' partial support comes after both outfits in 2019 agitated against Baumann's leadership, recommending a historic no-confidence vote against the CEO. READ MORE